GlaxoSmithKline PLC
A biopharmaceutical company developing vaccines and specialty medicines to prevent and treat disease.
GSK | IL
Overview
Corporate Details
- ISIN(s):
- GB00BN7SWP63 (+1 more)
- LEI:
- 5493000HZTVUYLO1D793
- Country:
- United Kingdom
- Address:
- 79 NEW OXFORD STREET, WC1A 1DG LONDON
- Website:
- https://www.gsk.com/en-gb/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
GSK is a global biopharmaceutical company that unites science, technology, and talent to prevent and treat disease. The company focuses on the discovery, development, and manufacturing of innovative vaccines and specialty medicines. Its core research and development efforts are concentrated in four therapeutic areas: infectious diseases, HIV, oncology, and immunology/respiratory. Formed in 2000 by the merger of Glaxo Wellcome and SmithKline Beecham, GSK has since sharpened its focus on biopharmaceuticals, notably after the 2022 demerger of its consumer healthcare business. The company is committed to improving global health by making its products accessible and affordable worldwide through strategic partnerships and access programs.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-11-04 08:20 |
Transaction in Own Shares
Transaction in Own Shares
|
English | 636.1 KB | ||
| 2025-11-03 19:48 |
Transaction in Own Shares
Transaction in Own Shares
|
English | 583.0 KB | ||
| 2025-11-03 16:10 |
Declaration of Voting Results & Voting Rights Announcements
Total Voting Rights
|
English | 4.9 KB | ||
| 2025-10-31 08:00 |
Transaction in Own Shares
Transaction in Own Shares
|
English | 421.8 KB | ||
| 2025-10-30 16:30 |
Director's Dealing
Director/PDMR Shareholding
|
English | 29.1 KB | ||
| 2025-10-30 08:00 |
Transaction in Own Shares
Transaction in Own Shares
|
English | 374.8 KB | ||
| 2025-10-29 08:05 |
Transaction in Own Shares
Transaction in Own Shares
|
English | 595.0 KB | ||
| 2025-10-29 08:00 |
Earnings Release
3rd Quarter Results
|
English | 1.3 MB | ||
| 2025-10-23 08:00 |
Transaction in Own Shares
Transaction in Own Shares
|
English | 595.0 KB | ||
| 2025-10-22 08:05 |
Environmental & Social Information
Positive data for low carbon version Ventolin MDI
|
English | 24.6 KB | ||
| 2025-10-22 08:00 |
Transaction in Own Shares
Transaction in Own Shares
|
English | 501.0 KB | ||
| 2025-10-22 08:00 |
Legal Proceedings Report
Latozinemab data read out
|
English | 18.8 KB | ||
| 2025-10-21 08:05 |
Regulatory News Service
Positive CHMP Opinion for GSK on Shingrix PFS
|
English | 28.8 KB | ||
| 2025-10-21 08:00 |
Transaction in Own Shares
Transaction in Own Shares
|
English | 480.8 KB | ||
| 2025-10-21 08:00 |
Regulatory News Service
GSK share positive Ph3 data on tebipenem HBr
|
English | 33.7 KB |
Automate Your Workflow. Get a real-time feed of all GlaxoSmithKline PLC filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for GlaxoSmithKline PLC
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for GlaxoSmithKline PLC via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
